- Product
- Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13
- Recalling company
- Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
- Classification
- Class III
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- USA nationwide.
- Initiated
- Apr 9, 2024
- FDA report date
- May 1, 2024